Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dice Therapeutics Inc (NQ: DICE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 8, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 47.45 (10) Ask (Size) 47.81 (2) Prev. Close 47.55 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs September 01, 2023 Via Investor Brand Network Exposures Product Safety Why These 3 Large Caps Are Bucking the August Slump August 22, 2023 The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023. Via MarketBeat Topics Economy Stocks Exposures Fossil Fuels Interest Rates US Equities Performance More News Read More What 9 Analyst Ratings Have To Say About DICE Therapeutics August 09, 2023 Via Benzinga Analyst Expectations for DICE Therapeutics's Future June 20, 2023 Via Benzinga Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics June 20, 2023 Via Benzinga Top 5 Health Care Stocks That May Crash In Q3 August 07, 2023 Via Benzinga Eli Lilly To Report Q2 Earnings: What's In The Cards? August 05, 2023 Via Talk Markets M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) July 26, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022 July 17, 2023 Via Benzinga DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE July 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire Why Shares of Ventyx Biosciences Rose Monday July 03, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023 June 26, 2023 Via Benzinga Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review June 23, 2023 Via Investor's Business Daily Why Dice Therapeutics Stock Bolted Higher This Week June 22, 2023 Via The Motley Fool Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event? June 21, 2023 Via The Motley Fool DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE June 21, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 June 21, 2023 Via Benzinga Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover June 21, 2023 Via MarketBeat Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know June 20, 2023 Via The Motley Fool Crude Oil Down 2%; Dragonfly Energy Shares Plunge June 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 20, 2023 Via Benzinga Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher June 20, 2023 Via Benzinga Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 20, 2023 Via Benzinga Eli Lilly (NYSE: LLY) Acquires DICE Therapeutics (NASDAQ: DICE): A New Step in Autoimmune Disease Treatments June 20, 2023 Via Spotlight Growth Why Shares of Dice Therapeutics Are Skyrocketing Tuesday June 20, 2023 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.